Characterizing autoimmunity NOD mouse islets, PLN/spleen
Characterizing autoimmunity NOD mouse islets, PLN/spleen
批准号:
7210042
负责人:
DANIEL KAUFMAN
金额:
$23.18万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2008-08-31
关键词:
NOD mouseT lymphocyteantibody specificityautoantigensautoimmune disorderbiomarkercytotoxic T lymphocytedevelopmental immunologyenzyme linked immunosorbent assayhelper T lymphocyteimmune tolerance /unresponsivenessinsulin dependent diabetes mellituslymph nodespancreatic isletspathologic processphenotypespleen
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Scientific Abstract: We lack a basic understanding how spontaneous autoimmune disease arises. Studies of antigen-tolerized transgenic NOD mice have suggested the primacy of different autoantigens in initiating the autoimmunity that leads to type 1 diabetes (T1D). However, theoretical considerations based on our knowledge of T cell tolerance induction predict that beta-cell autoimmunity should be initially lost to many beta-cell antigens simultaneously but there is little experimental evidence in support of this scenario. We have developed a modified ELISPOT assay that enables the characterization of autoreactive T cells within the pancreatic lymph nodes (PLN) and islet-infiltrating T cell population. Our preliminary data indicate that antigen-specificity and phenotype of autoreactive T cells within the target tissue is quite different from the current picture that was obtained through analysis of T cell populations in the periphery of NOD mice. We expect that our further longitudinal characterization of autoreactive CD4+ and CD8+ T cell responses in the PLN, islets and spleen will lead to a new conceptualization of the autoimmune processes in NOD mice. Our analysis of the functional avidity of early T cell autoreactivity in the PLN and islets will provide an independent line of evidence to support either the "hierarchal" or the "simultaneous" model of the development of T cell autoimmunity. The lessons learned will support/refute the hypothesis that autoimmunity can be circumvented by tolerizing individuals to "initiating" target antigens. Our studies will also elucidate the relationship between peripheral T cell responses and those in the target tissue. As only PBMC are available from humans, understanding the relationship between T cell autoreactivities in the periphery and target tissue is important to assess the feasibility of using T cell-based markers to monitor disease progression, the efficacy of interventive therapies, and the status of transplanted islets. Laypersons: We lack a basic understanding how spontaneous autoimmune disease arises. We have established the ability to directly characterize autoreactive T cells within the pancreatic lymph nodes (PLN, wherein autoimmunity is thought to first arise) and the islet-infiltrating T cell population, which heretofore has not been feasible. We expect that the results of this proposal will lead to a new conceptualization of the autoimmune process in NOD mice. The same basic processes may also occur in human organ-specific autoimmune diseases. The results will help guide our thinking on potential therapeutic approaches, as well as the utility of biomarkers based on peripheral T cell responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Oral GABA treatment as a novel and safe therapy to ameliorate Sjögren’s syndrome
-
批准号:9808690
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2019
-
负责人:DANIEL KAUFMAN
-
依托单位:
Combination immunotherapy to preserve beta-cell function in the context of autoimmunity
-
批准号:9035769
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:DANIEL KAUFMAN
-
依托单位:
Combination immunotherapy to preserve beta-cell function in the context of autoimmunity
-
批准号:9198975
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2016
-
负责人:DANIEL KAUFMAN
-
依托单位:
Reversal of T1D in NOD mice using a safe combination therapy
-
批准号:8292993
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2012
-
负责人:DANIEL KAUFMAN
-
依托单位:
Reversal of T1D in NOD mice using a safe combination therapy
-
批准号:8464092
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2012
-
负责人:DANIEL KAUFMAN
-
依托单位:
Reversal of T1D in NOD mice using a safe combination therapy
-
批准号:8665415
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2012
-
负责人:DANIEL KAUFMAN
-
依托单位:
Multimodality imaging of beta-cell in anaimal models of T1DM and T2DM
-
批准号:7690828
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2008
-
负责人:DANIEL KAUFMAN
-
依托单位:
Multimodality imaging of beta-cell in anaimal models of T1DM and T2DM
-
批准号:7588447
-
项目类别:
-
资助金额:$18.78万
-
财政年份:2008
-
负责人:DANIEL KAUFMAN
-
依托单位:
Characterizing MHCI's neuroactivity
-
批准号:7345643
-
项目类别:
-
资助金额:$16.88万
-
财政年份:2006
-
负责人:DANIEL KAUFMAN
-
依托单位:
Characterizing MHCI's neuroactivity
-
批准号:7018998
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2006
-
负责人:DANIEL KAUFMAN
-
依托单位:
Characterizing autoimmunity in NOD mouse islets, PLN and spleen
-
批准号:7295772
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2006
-
负责人:DANIEL KAUFMAN
-
依托单位:
A Neuroprotective Vaccine for Parkinson's Disease
-
批准号:7050568
-
项目类别:
-
资助金额:$16.34万
-
财政年份:2005
-
负责人:DANIEL KAUFMAN
-
依托单位:
A Neuroprotective Vaccine for Parkinson's Disease
-
批准号:6922302
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2005
-
负责人:DANIEL KAUFMAN
-
依托单位:
MHC I Inhibition of Neuronal Repair Responses
-
批准号:6820518
-
项目类别:
-
资助金额:$21.29万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
Noninvasive PET Imaging of Islet Grafts
-
批准号:6954643
-
项目类别:
-
资助金额:$38.29万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
MHCI Inhibition of Neuronal Repair Responses
-
批准号:6897885
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
Noninvasive islet graft imaging by PET
-
批准号:6944314
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
Noninvasive islet graft imaging by PET
-
批准号:6816013
-
项目类别:
-
资助金额:$23.05万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
Noninvasive PET Imaging of Islet Grafts
-
批准号:6861529
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2004
-
负责人:DANIEL KAUFMAN
-
依托单位:
Prevention of IDDM by Expression of a Modified I-Ag7
-
批准号:6523687
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2001
-
负责人:DANIEL KAUFMAN
-
依托单位:
海外基金